Role of Haritaki Churna and Navak Guggulu in the treatment of high blood cholesterol levels

A study to determine the effect of Haritaki Churna and Navak Guggulu in the management of hyperlipidemia a randomized controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059251

Enrollment

Registered

2023-10-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age limit from 25 to 60 yrs. 2. Patient irrespective of age, sex, religion etc. of hyperlipidemia. 3. Obese and non-obese hyperlipidemic patients (BMI-18.50 to 40.00 kg/m2 as per New Updated WHO classification of BMI of 2004) 4. Patients with controlled Type 2 diabetes mellitus ( Fasting 5. Patients with high blood lipid profile. Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia a. Patient having Serum Total Cholesterol Level >200mg/dl. b. Patient having Serum Triglycerides Level > 150 mg/dl. c. Patient having Serum LDL Cholesterol Level >130mg/dl. d. Patient having serum VLDL Cholesterol Level > 40 mg/dl. e. Patient having Serum HDL Cholesterol Level < 40 mg/dl.

Exclusion criteria

Exclusion criteria: 1. Patients having a history of untreated thyroid disorder. 2. Pregnant women & lactating mother. 3. Chronic illness and infection like TB, CA and HIV infection. 4. Patient is suffering with psychological disorders like anxiety, depression. 5. Patient with Respiratory Diseases Complications, Coronary Heart Disease, Hepatic or Renal Disease etc. 6. Patients having drug induced hyperlipidemia like steroids.

Design outcomes

Primary

Measure	Time frame
Reduction in the values of Lipid Profile like Total Cholesterol, Serum Triglycerides, LDL, VLDL and increase in HDL levelsTimepoint: 60 days	—

Secondary

Measure	Time frame
Efficacy of drugs used in trial Timepoint: 30 & 60 days	—

Countries

India

Contacts

Public ContactDr Archana Dachehwar

Shri Ayurved Mahavidyalaya Nagpur

dr.dachewar@gmail.com9822206312

Outcome results